SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $590 | -88.2% | 3,209 | -23.1% | 0.00% | – |
| Q2 2023 | $4,986 | +83.9% | 4,172 | +6.3% | 0.00% | – |
| Q1 2023 | $2,711 | +90.2% | 3,923 | +87.0% | 0.00% | – |
| Q4 2022 | $1,425 | -52.5% | 2,098 | -36.5% | 0.00% | – |
| Q3 2022 | $3,000 | -96.9% | 3,304 | -97.7% | 0.00% | – |
| Q2 2022 | $98,000 | -76.4% | 144,819 | -70.9% | 0.00% | – |
| Q1 2022 | $416,000 | +127.3% | 496,967 | +342.1% | 0.00% | – |
| Q4 2021 | $183,000 | +1120.0% | 112,415 | +1682.7% | 0.00% | – |
| Q3 2021 | $15,000 | -93.5% | 6,306 | -92.8% | 0.00% | – |
| Q2 2021 | $232,000 | -36.6% | 87,822 | +19.9% | 0.00% | – |
| Q1 2021 | $366,000 | – | 73,265 | +1046542.9% | 0.00% | – |
| Q2 2020 | $0 | – | 7 | +600.0% | 0.00% | – |
| Q2 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENDELL JEFFREY L | 4,933,024 | $4,133,000 | 0.30% |
| ACUTA CAPITAL PARTNERS, LLC | 295,896 | $248,000 | 0.12% |
| Connacht Asset Management LP | 231,551 | $194,000 | 0.10% |
| Uniplan Investment Counsel, Inc. | 1,564,605 | $1,310,000 | 0.08% |
| AdvisorShares Investments LLC | 358,796 | $301,000 | 0.05% |
| 1492 Capital Management LLC | 99,819 | $84,000 | 0.04% |
| Woodline Partners LP | 2,803,230 | $2,349,000 | 0.04% |
| Ikarian Capital, LLC | 257,883 | $215,000 | 0.03% |
| Sovereign Financial Group, Inc. | 75,000 | $63,000 | 0.02% |
| Aquatic Capital Management LLC | 6,400 | $5,000 | 0.01% |